Nanox.AI, a subsidiary of Nanox Imaging Ltd., has signed a distribution agreement with Thailand's Dosy Health to introduce its AI-powered CT-based cardiac imaging solution, HealthCCSng, in the Thai healthcare market. This collaboration leverages Dosy Health's strong local ties with major universities and hospitals, including the BDMS network, to support integration and commercialization efforts. The AI solution analyzes routine CT scans to provide coronary artery calcium measurements, aiming to enhance early detection and preventive care. The partnership is part of Nanox.AI's broader strategy to expand internationally and improve clinical insights through AI, with future plans to explore additional imaging applications.
Nanox.AI's recent collaboration with Dosy Health to introduce an AI cardiac imaging solution in Thailand is presented here with Pluang's Health sector market data as of Nov 10, 2026 19:42 WIB. Of 150 priced Health-sector US stocks tradable on Pluang, 83 rose and 55 fell today. Notable movers include BKD at USD 10.30 with a 1-day change of +10.63%, LQDA at USD 49.97 with +4.39%, and CGC at USD 0.65 with +4.37%.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
